Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Tardive Dyskinesia (TD) Treatment Drugs Market Portraiture
2.1.1. Global Tardive Dyskinesia Treatment Drugs Market, by Drug Type, 2017 (US$ Mn)
2.1.2. Global Tardive Dyskinesia Treatment Drugs Market, by Geography, 2017 (Value %)
Chapter 3. Tardive Dyskinesia (TD) Treatment Drugs: Market Dynamics and Outlook
3.1. Market Definition and Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2017
Chapter 4. Global Tardive Dyskinesia (TD) Treatment Drugs Market, by Drug Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Valbenazine
4.3. Deutetrabenazine
4.4. Other
Chapter 5. Global Tardive Dyskinesia (TD) Treatment Drugs Market, by Geography, 2016 – 2026
5.1. Overview
5.2. North America Tardive Dyskinesia Treatment Drugs Market Analysis, 2016 – 2026
5.2.1. North America Tardive Dyskinesia Treatment Drugs Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.2.2. North America Tardive Dyskinesia Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Tardive Dyskinesia Treatment Drugs Market Analysis, 2016 – 2026
5.3.1. Europe Tardive Dyskinesia Treatment Drugs Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.3.2. Europe Tardive Dyskinesia Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Tardive Dyskinesia Treatment Drugs Market Analysis , 2016 – 2026
5.4.1. Asia Pacific Tardive Dyskinesia Treatment Drugs Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Tardive Dyskinesia Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of APAC
5.5. Latin America Tardive Dyskinesia Treatment Drugs Market Analysis , 2016 – 2026
5.5.1. Latin America Tardive Dyskinesia Treatment Drugs Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.5.2. Latin America Tardive Dyskinesia Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa (MEA) Tardive Dyskinesia Treatment Drugs Market Analysis, 2016 – 2026
5.6.1. MEA Tardive Dyskinesia Treatment Drugs Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.6.2. MEA Tardive Dyskinesia Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA
Chapter 6. Company Profiles
6.1. Auspex Pharmaceuticals
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Neurocrine Biosciences, Inc.
6.3. Synchroneuron Inc.
6.4. Teva Pharmaceutical Industries Ltd.
6.5. Other Notable Players
List of Figures
FIG. 1 Tardive Dyskinesia (TD) Treatment Drugs: Market Segmentation
FIG. 2 Global Tardive Dyskinesia Treatment Drugs Market, by Drug Type, 2017 (US$ Mn)
FIG. 3 Global Tardive Dyskinesia Treatment Drugs Market, by Geography, 2017 (Value %)
FIG. 4 Attractive Investment Proposition, by Geography, 2017
FIG. 5 Market Competition Landscape, by Key Players, 2017
FIG. 6 Global Valbenazine Market, 2016 – 2026 (US$ Mn)
FIG. 7 Global Deutetrabenazine Market, 2016 – 2026 (US$ Mn)
FIG. 8 Global Other TD Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 9 U.S. Tardive Dyskinesia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 10 Canada Tardive Dyskinesia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 11 U.K. Tardive Dyskinesia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 12 Germany Tardive Dyskinesia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 13 Rest of Europe Tardive Dyskinesia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 14 Japan Tardive Dyskinesia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 15 China Tardive Dyskinesia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 16 Rest of Asia Pacific Tardive Dyskinesia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 17 Brazil Tardive Dyskinesia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 18 Mexico Tardive Dyskinesia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 19 Rest of Latin America Tardive Dyskinesia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 20 GCC Tardive Dyskinesia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 21 Rest of Middle East and Africa Tardive Dyskinesia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
List of Tables
Table 1 Global Tardive Dyskinesia Treatment Drugs Market, by Drug Type, 2016 – 2026 (US$ Mn)
Table 2 North America Tardive Dyskinesia Treatment Drugs Market, by Drug Type, 2016 – 2026 (US$ Mn)
Table 3 North America Tardive Dyskinesia Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
Table 4 Europe Tardive Dyskinesia Treatment Drugs Market, by Drug Type, 2016 – 2026 (US$ Mn)
Table 5 Europe Tardive Dyskinesia Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
Table 6 Asia Pacific Tardive Dyskinesia Treatment Drugs Market, by Drug Type, 2016 – 2026 (US$ Mn)
Table 7 Asia Pacific Tardive Dyskinesia Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
Table 8 Latin America Tardive Dyskinesia Treatment Drugs Market, by Drug Type, 2016 – 2026 (US$ Mn)
Table 9 Latin America Tardive Dyskinesia Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
Table 10 Middle East and Africa Tardive Dyskinesia Treatment Drugs Market, by Drug Type, 2016 – 2026 (US$ Mn)
Table 11 Middle East and Africa Tardive Dyskinesia Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)